What Causes The Emerging Trend Of Stroke Therapeutics Market Industry In US

Posted by Loise Williams on October 17th, 2019

A stroke is also known as a brain attack, occurs when the blood supply to the brain is blocked by a clot or by rupturing of a blood vessel. In a stroke, parts of the brain become damaged or die. A stroke can lead to long-lasting brain damage, long-term disability, or even death. As per the latest market research report published by Technavio, the global stroke therapeutics market size will grow by USD 1.37 billion during 2019-2023. Get the free sample report below for the detailed information.

Download the free sample report @ http://bit.ly/33Bilsl

There is huge need for safe and innovative novel therapies to treat stroke owing to the high prevalence of stroke. Hence, several companies are developing novel drugs for the treatment of stroke. The development of stem cell therapy will have a major impact on upcoming stroke therapeutics, as it has fewer side effects and regenerative properties. For instance, Athersys is developing MultiStem, it is a cell therapy regenerative medicine product currently in Phase III clinical development for the treatment of ischemic strokes. 

Furthermore, ZZ Biotech LLC is developing a novel recombinant variant of human activated protein C molecule, known as 3K3A-APC. This molecule completed a Phase II clinical trial for the treatment of acute ischemic strokes. Hence, the development of such novel therapies with fewer side-effects is expected to contribute to the growth of the global stroke therapeutics market at a CAGR of 4.93% during the forecast period.